Page Comparison

Versions Compared

Key

This line was added.
This line was removed.
Formatting was changed.

Ali, F., Kaura, A., Russell, C., Bonn, M., Bruneau, J., Dasgupta, N., Imtiaz, S., Martel-Laferrière, V., Rehm, J., Shahin, R. & Elton-Marshall, T. 2023. Identifying Barriers and Facilitators to Covid-19 Vaccination Uptake among People Who Use Drugs in Canada: A National Qualitative Study. Harm Reduction Journal, 20(1):99.

Ali, F., Russell, C., Greer, A., Bonn, M., Werb, D. & Rehm, J. 2023. "2.5 G, I Could Do That before Noon": A Qualitative Study on People Who Use Drugs' Perspectives on the Impacts of British Columbia's Decriminalization of Illegal Drugs Threshold Limit. Subst Abuse Treat Prev Policy, 18(1):32.

Ali, F., Russell, C., Kaura, A., Leslie, P., Bayoumi, A.M., Hopkins, S. & Wells, S. 2023. Client Experiences Using a New Supervised Consumption Service in Sudbury, Ontario: A Qualitative Study. PLOS ONE, 18(10):e0292862.

Ali, F., Russell, C., Law, J., Talbot, A., Elton-Marshall, T., Bozinoff, N., Imtiaz, S., Rehm, J., Giang, V. & Rush, B. 2023. Withdrawal Management Practices and Services in Canada: A Cross-Sectional National Survey on the Management of Opioid Use Disorder. Canadian Journal of Addiction, 14(1):6-14.

Ferguson, M., Rittenbach, K., Leece, P., Adams, A., Ali, F., Elton-Marshall, T., Burmeister, C., Brothers, T.D., Medley, A., Choisil, P., Strike, C., Ng, J., Lorenzetti, D.L., Gallant, K. & Buxton, J.A. 2023. Guidance on Take-Home Naloxone Distribution and Use by Community Overdose Responders in Canada. Canadian Medical Association Journal, 195(33):E1112-E1123.

Imtiaz, S., Nigatu, Y.T., Ali, F., Douglas, L., Hamilton, H.A., Rehm, J., Rueda, S., Schwartz, R.M., Wells, S. & Elton-Marshall, T. 2023. Cannabis Legalization and Cannabis Use, Daily Cannabis Use and Cannabis-Related Problems among Adults in Ontario, Canada (2001–2019). Drug and Alcohol Dependence, 244:109765.

Russell, C., Law, J., Imtiaz, S., Rehm, J., Le Foll, B. & Ali, F. 2023. The Impact of Methamphetamine Use on Medications for Opioid Use Disorder (Moud) Treatment Retention: A Scoping Review. Addict Sci Clin Pract, 18(1):48.